PARABOL
contains Trenbolone Hexahydrobenzylcarbonate 76.5 mg/ml, an intramuscular
injectable androgenic–anabolic medication used in highly specific medical
contexts related to hormone-modulating cancer care. It supports therapeutic
goals where estrogen suppression and anabolic balance may be required under
controlled medical supervision.
Uses
Supports
treatment of hormone-responsive breast cancer.
Helps
reduce estrogen activity in specific therapies.
Assists
in preserving muscle mass in clinical conditions.
Used in
selective hormone-modulation programs.
Part of
supportive oncology treatment protocols under supervision.
